Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

LGR5 mainly stays inside cells, moving to the trans-Golgi network, and this process is important for its role in cell signaling.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

A new gene mutation linked to Olmsted syndrome may increase cancer risk, suggesting the need for ongoing patient monitoring.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Low-level light therapy safely improves hair growth and thickness for androgenetic alopecia.

EGM2 and SOX2 help form beige adipocytes by maintaining ASC immaturity and activating brown adipocytes.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

THSG from a Chinese plant helps with aging and related diseases.

OCIAD2 and DCN genes affect hair growth in goats by having opposite effects on a growth signaling pathway and inhibiting each other.

CTLA4 gene variants are not linked to alopecia areata in Monterrey's Mexican population.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Targeting ATM could help manage heart cell enlargement due to pressure overload.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

New treatments for androgenetic alopecia are emerging, improving hair loss management.

Continuous treatment is essential to manage male pattern baldness effectively.

LGD1069 effectively prevents breast tumors in mice without toxicity.

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.